Generali Investments Management’s Bristol-Myers Squibb BMY Stock Holding History

Generali Investments Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$995K	Hold	17,276	–	–	0.22%	78
2026 Q1	$1.05M	Buy	17,276 +1,133	+7%	+$66K	0.24%	75
2025 Q4	$871K	Hold	16,143	–	–	0.17%	83
2025 Q3	$728K	Sell	16,143 -2,154	-12%	-$101K	0.15%	93
2025 Q2	$846K	Sell	18,297 -10,268	-36%	-$504K	0.19%	92
2025 Q1	$1.74M	Buy	28,565 +8,691	+44%	+$507K	0.5%	53
2024 Q4	$1.12M	Buy	+19,874	New	+$1.11M	0.29%	71

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Generali Investments Management's BMY Position: Q2 2026 in Review

Generali Investments Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 17,276 shares worth $995K. The position accounts for 0.22% of the portfolio, ranked #78.

Generali Investments Management first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.74M in Q1 2025. 895 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Generali Investments Management held 17,276 shares of Bristol-Myers Squibb worth $995K as of Q2 2026.
Generali Investments Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.22% of Generali Investments Management's portfolio in Q2 2026, its #78 holding.
Generali Investments Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Generali Investments Management's Bristol-Myers Squibb position peaked at $1.74M in Q1 2025.
895 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Generali Investments Management's 13F filing for Q2 2026, filed 10 Jul 2026.